DUSP5
Basic information
Region (hg38): 10:110497907-110511533
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the DUSP5 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 19 | 20 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 19 | 1 | 2 |
Variants in DUSP5
This is a list of pathogenic ClinVar variants found in the DUSP5 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
10-110498205-C-G | not specified | Uncertain significance (Nov 24, 2024) | ||
10-110498209-C-T | not specified | Uncertain significance (Feb 06, 2023) | ||
10-110498233-A-T | not specified | Uncertain significance (Jul 17, 2023) | ||
10-110498239-C-T | not specified | Uncertain significance (Aug 14, 2024) | ||
10-110498260-C-T | not specified | Uncertain significance (Mar 29, 2023) | ||
10-110498261-T-C | not specified | Uncertain significance (Feb 27, 2024) | ||
10-110498284-G-T | Benign (Feb 16, 2018) | |||
10-110498288-G-C | not specified | Uncertain significance (Dec 06, 2023) | ||
10-110498303-C-G | not specified | Uncertain significance (Nov 15, 2021) | ||
10-110498312-A-G | not specified | Uncertain significance (May 13, 2024) | ||
10-110498325-C-A | not specified | Uncertain significance (Dec 22, 2023) | ||
10-110498354-A-T | not specified | Uncertain significance (Aug 17, 2021) | ||
10-110498401-C-T | not specified | Uncertain significance (Jun 06, 2023) | ||
10-110502729-G-C | not specified | Uncertain significance (Feb 05, 2024) | ||
10-110502761-C-T | Likely benign (Apr 01, 2022) | |||
10-110502762-G-T | not specified | Uncertain significance (Nov 26, 2024) | ||
10-110502765-G-A | not specified | Uncertain significance (Aug 21, 2024) | ||
10-110502768-G-A | not specified | Uncertain significance (Mar 23, 2023) | ||
10-110502820-A-G | not specified | Uncertain significance (Sep 09, 2024) | ||
10-110502832-C-G | not specified | Uncertain significance (May 28, 2024) | ||
10-110506997-C-G | not specified | Uncertain significance (Mar 20, 2023) | ||
10-110510088-A-C | not specified | Uncertain significance (Dec 13, 2022) | ||
10-110510125-G-A | not specified | Uncertain significance (Nov 09, 2023) | ||
10-110510140-T-C | not specified | Uncertain significance (Jun 26, 2024) | ||
10-110510142-G-A | not specified | Uncertain significance (Nov 19, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
DUSP5 | protein_coding | protein_coding | ENST00000369583 | 4 | 13707 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00332 | 0.954 | 125738 | 0 | 10 | 125748 | 0.0000398 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.694 | 182 | 210 | 0.865 | 0.0000108 | 2410 |
Missense in Polyphen | 35 | 56.807 | 0.61612 | 677 | ||
Synonymous | -0.559 | 102 | 95.1 | 1.07 | 0.00000535 | 811 |
Loss of Function | 1.77 | 6 | 12.9 | 0.466 | 5.46e-7 | 155 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000289 | 0.0000289 |
Ashkenazi Jewish | 0.0000993 | 0.0000992 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.0000463 | 0.0000462 |
European (Non-Finnish) | 0.0000528 | 0.0000439 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Dual specificity protein phosphatase; active with phosphotyrosine, phosphoserine and phosphothreonine residues. The highest relative activity is toward ERK1. {ECO:0000269|PubMed:7961985}.;
- Pathway
- MAPK signaling pathway - Homo sapiens (human);EGF-Ncore;Endoderm Differentiation;Signal Transduction;ATF-2 transcription factor network;RAF-independent MAPK1/3 activation;Negative regulation of MAPK pathway;RAF/MAP kinase cascade;MAPK1/MAPK3 signaling;MAPK family signaling cascades;Direct p53 effectors
(Consensus)
Recessive Scores
- pRec
- 0.252
Intolerance Scores
- loftool
- 0.375
- rvis_EVS
- 1.37
- rvis_percentile_EVS
- 94.52
Haploinsufficiency Scores
- pHI
- 0.383
- hipred
- Y
- hipred_score
- 0.800
- ghis
- 0.413
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.982
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Dusp5
- Phenotype
- homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; neoplasm; immune system phenotype; hematopoietic system phenotype;
Gene ontology
- Biological process
- MAPK cascade;activation of MAPK activity;inactivation of MAPK activity;protein dephosphorylation;dephosphorylation;peptidyl-tyrosine dephosphorylation;peptidyl-threonine dephosphorylation
- Cellular component
- nucleus;nucleoplasm;cytoplasm
- Molecular function
- protein tyrosine phosphatase activity;protein binding;protein tyrosine/serine/threonine phosphatase activity;phosphatase activity;MAP kinase tyrosine/serine/threonine phosphatase activity